Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Administered Shingrix liquid without mixing the powder; Administered Shingrix liquid without mixing the powder; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 11-JUN-2025, the patient received Shingrix. On 11-JUN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Administered Shingrix liquid without mixing the powder) and inappropriate dose of vaccine administered (Verbatim: Administered Shingrix liquid without mixing the powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 01-JUL-2025 The registered nurse reported that a nurse gave Shingrix liquid without mixing the powder to patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter had 2 different lot numbers for Shingrix on the date of administration, and they did not know which one was administered to the patients, it could be 3J2S2 with expiration date of 27th March, 2027, or 2HJ99 with expiration date of 4th April, 2027. This case has been linked with US2025082618, by same reporter for different patient; Sender's Comments: US-GSK-US2025082618:Same reporter/Diffrent patient